Sensitivity analyses varying daily treatment costs and ward stay for chemo/alloHSCT patients reduced cost differences to - $ 941 per patient ( p = 0.21 ) across the whole trial and - $ 2927 per patient ( p < 0.05 ) in chemo/alloHSCT subgroup .